Seizure drug showdown: granules vs tablets in healthy volunteers

NCT ID NCT07393022

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a new granule form of the seizure medicine levetiracetam works the same as the standard tablet form. Twenty healthy adults took both versions under fasting conditions. The goal was to check if the body absorbs the medicine similarly, which helps ensure the new form is a reliable alternative.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIOEQUIVALENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Biopharma Services Inc.

    Toronto, Ontario, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.